Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis

PLoS Medicine - United States
doi 10.1371/journal.pmed.1001330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Pin37 - Cost-Effectiveness of Rotavirus Vaccination in the Netherlands – A Disease Transmission Dynamic Modeling Approach

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Routine Rotavirus Vaccination in Brazil

Revista Panamericana de Salud Publica/Pan American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2008English

Impact of Rotavirus Vaccination in Australian Children Below 5 Years of Age

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Benefit Restrictions and Gout Treatment

Journal of Managed Care Pharmacy
2013English

Cost-Benefit Analysis of Influenza Vaccination in a Public Healthcare Unit

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2006English

Coding Error in Analysis of Rotavirus Vaccination and Type 1 Diabetes

JAMA Pediatrics
Child HealthPediatricsPerinatology
2019English

Trastuzumab Cardiotoxiciy: The Age-Old Balance of Risk and Benefit

British Journal of Cancer
Cancer ResearchOncology
2016English

Cost/Benefit Analysis Comparing Ex Situ Treatment Technologies for Removing Carbon Tetrachloride From Hanford Groundwater

1993English

PND9 the Role of Spontaneous Events Databases for Benefit-Risk Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy